A global shortage of IV fluids, driven by surging demand and manufacturing constraints, has prompted urgent action by the Commonwealth, states and territories.
To alleviate the shortage, the Federal Government has partnered with local producers and suppliers to secure over 22 million additional IV fluid bags over the next six months, surpassing forecast demand.
Baxter, a key manufacturer, is producing IV fluids at record levels at its Sydney site and plans to expand its local manufacturing capacity soon, reported the Federal Department of Health.
A cross-jurisdictional response group, including private hospitals and primary care representatives, has been formed to address the issue.
The group met this week and reported that the situation has stabilised in most areas but will continue to meet weekly, or more frequently if needed, while supply remains tight.
The TGA is also alerting staff to use IV stock judiciously, with service prioritisation decisions managed at the state and territory level.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Aug 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Aug 24
